Ichiro Abe. 2020. “Efficacy and Safety of Low-Dose Ipragliflozin, a Selective Sodium Glucose Transporter 2 Inhibitor, in Patients With Type 2 Diabetes Mellitus”. International Journal of Allied Medical Sciences and Clinical Research 4 (3):376-82. https://doi.org/10.61096/ijamscr.v4.iss3.2016.376-382.